PHosted onPRISM
Platform for Research & Internal Systems Management

International Delphi Consensus Study

Standardizing Post-ERCP Pancreatitis Definitions & Research Priorities

Δ

Johns Hopkins University · Radboud University Medical Center

An international expert panel converging, round by round, on the criteria that should govern how PEP is defined, risk-stratified, and studied in clinical trials.

Panel access is currently available · responses are confidential and anonymized

ISecure & Confidential

Panelist identities are held separately from their responses. Ratings and comments are analyzed and reported only in anonymized, aggregate form.

IIExpert Panel

An international panel of gastroenterologists and endoscopists with recognized expertise in ERCP and its complications.

IIIAnonymized Feedback

After each round closes, the panel receives an anonymized summary of the group’s responses and reconsiders its positions in the next round, toward consensus.

The Study

About this study

DELPHI CONSENSUS RECOMMENDATIONS ON STANDARDIZING POST-ERCP PANCREATITIS DEFINITIONS, RESEARCH PRIORITIES — Johns Hopkins University

Post-ERCP pancreatitis (PEP) is the most frequent and clinically significant complication of endoscopic retrograde cholangiopancreatography. Despite extensive investigation, its definition, the stratification of patient- and procedure-related risk, and the design of preventive trials remain inconsistent across the literature, limiting comparison between studies and cumulative progress. This international Delphi study convenes experts in pancreaticobiliary endoscopy to develop consensus recommendations that standardize how PEP is defined and risk-stratified, and that establish priorities for the design of future clinical trials. Across successive, anonymized rounds, panelists rate a structured set of statements and reconsider their positions in light of the panel's aggregated responses until consensus is reached.

The Process

How the Delphi process works

1
Step 1 — Respond

Rate each statement in the questionnaire, adding a brief comment wherever you wish to qualify your position.

2
Step 2 — Aggregate

Responses are pooled and de-identified; no individual rating or comment is attributed to a named panelist.

3
Step 3 — Feedback

After each round, the anonymized distribution of the panel’s responses is returned, and panelists reconsider their positions toward consensus.

The Panel

Study Team

Principal Investigator

Venkata S. Akshintala
Venkata S. Akshintala, MD, PhD
Associate Professor
Division of Gastroenterology & Hepatology · Johns Hopkins University School of Medicine
vakshin1@jhmi.edu

Study Coordinators

Richu Ravikumar
Richu Ravikumar, MBBS
Post-Doctoral Research Fellow
Division of Gastroenterology & Hepatology · Johns Hopkins University School of Medicine
richu1499@outlook.com
Srived Meda
Srived Meda
Post-Doctoral Research Fellow
Division of Gastroenterology & Hepatology · Johns Hopkins University School of Medicine
smeda1@jh.edu

Steering Committee

Erwin J.M. van Geenen
Erwin J.M. van Geenen, MD, PhD
Dept. of Gastroenterology & Hepatology · Radboud University Medical Center
Christina J. Sperna Weiland
Christina J. Sperna Weiland, MD
Dept. of Gastroenterology & Hepatology · Radboud University Medical Center

Institutional Affiliations